DRUG: Nogapendekin alfa inbakicept
Help
Entry
D12888 Mixture Drug
Name
Nogapendekin alfa inbakicept;
Nogapendekin alfa inbakicept-pmln;
Anktiva (TN)
Product
ANKTIVA (Altor BioScience)
Component
Nogapendekin alfa [DR:
D11821
], Inbakicept [DR:
D11747
]
Remark
Product:
D12888<US>
Efficacy
Antineoplastic, IL-15 receptor agonist
Disease
Bladder cancer [DS:
H00022
]
Comment
Complex of Nogapendekin alfa [DR:
D11821
] and inbakicept [DR:
D11747
]
Target
IL15RA [HSA:
3601
] [KO:
K05074
]
Pathway
hsa04060
Cytokine-cytokine receptor interaction
hsa04630
JAK-STAT signaling pathway
hsa04672
Intestinal immune network for IgA production
hsa05200
Pathways in cancer
Brite
New drug approvals in the USA [
br08319.html
]
New molecular entities and new therapeutic biological products
D12888
New drug approvals in the USA, Europe and Japan [
br08328.html
]
Approval dates by FDA, EMA and PMDA
D12888
BRITE hierarchy
LinkDB
All DBs
» Japanese version
» Back
DBGET
integrated database retrieval system